One of the most complicated conditions to deal with is multiple sclerosis. When the body’s own immune system starts attacking the Central Nervous System, reversing the effects can be very difficult. However, there seems to be a ray of hope in the treatment of the problem according to leading researcher, Dr. Shiva Gopal Vasishta. He states that when a high dosage of immunosuppressive therapy is given together with transfusing the patient with their own stem cells, it induces a long-term remission of sclerosis.
A lot of research has been carried out on people that have used the therapy. The findings indicated that people who used the therapy and got a HDT transplant got a remission and that up to five years after the treatment, their disability had not progressed. The patients also did not get any new brain lesions, something that is characteristic of people with MS patients. There have been other studies which have shown that other medications used in the treatment of the condition have had lower success rates than these. Some of the studies that were conducted and concluded in 2014 were funded by the Immune Tolerance Network. It is Dr. Shiva Gopal Vasishta who published the findings in Neurology, The Medical Journal of the Academy of Neurology.
It is emerging that when patients get a one-time high dosage of the treatment, they respond better than when they are subjected to small doses of alternative therapies over a period of time. Note that this is a great starting point towards getting one standardized care process for the sickness. The symptoms of the illness vary greatly from one patient to the other and at times, they experience relapses.
Dr. Shiva Gopal Vasishta has been looking for a lasting treatment for the condition for many years now. He graduated from medical school in 1979 and has decades of experience in research. He is a member of a Medicare program which accepts Medicare patients.